Serigen Mediproducts Private Limited is an innovative tissue regeneration company that is revolutionizing the field of medical products. Led by a team of exceptional engineers and scientists with training from prestigious institutes such as MIT and the University of Delaware, they are dedicated to developing next-gen tissue repair solutions. With prior experience in top corporate and government R&D labs, including GE-Jack Welch Technology Center and National Chemical Laboratory, their team brings a wealth of expertise to the table.

Serigen's product portfolio includes Serioss, Seriderm, and Serimat, all aimed at advancing the field of orthopedics and head & face surgery. They have received grants from esteemed organizations like the Biotechnology Industry Research Assistance Council (BIRAC), which has enabled them to conduct clinical investigations and complete preclinical studies for their products. Backed by clinical advisors, regulatory specialists, medical industry experts, and angel investors, Serigen is well-positioned to make significant contributions to the medical industry.

Their dedication to innovation and commitment to excellence set them apart in the field of tissue regeneration